BGB-3111-304 (Beigene)

Trial description
An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma
Contact name
Dr George Follows
Trial start date
Wednesday, May 23, 2018
Trial end date
Thursday, February 28, 2019
Trial tumour type
Show on Radiotherapy